1. Home
  2. PMCB vs MEGL Comparison

PMCB vs MEGL Comparison

Compare PMCB & MEGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PharmaCyte  Biotech Inc.

PMCB

PharmaCyte Biotech Inc.

HOLD

Current Price

$0.55

Market Cap

6.3M

Sector

Health Care

ML Signal

HOLD

Logo Magic Empire Global Limited

MEGL

Magic Empire Global Limited

HOLD

Current Price

$1.21

Market Cap

5.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PMCB
MEGL
Founded
1996
2016
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
6.3M
5.8M
IPO Year
2001
2021

Fundamental Metrics

Financial Performance
Metric
PMCB
MEGL
Price
$0.55
$1.21
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
125.6K
12.6K
Earning Date
03-17-2026
04-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.53
$0.87
52 Week High
$1.51
$1.90

Technical Indicators

Market Signals
Indicator
PMCB
MEGL
Relative Strength Index (RSI) 35.67 54.13
Support Level $0.55 $1.16
Resistance Level $0.77 $1.40
Average True Range (ATR) 0.04 0.07
MACD 0.00 0.01
Stochastic Oscillator 31.02 84.21

Price Performance

Historical Comparison
PMCB
MEGL

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a biotechnology company focused on developing cellular therapies for cancer based on its proprietary cellulose-based live cell encapsulation technology, Cell-in-a-Box. The technology is intended to be used as a platform for therapies for several types of cancer, including locally advanced, inoperable pancreatic cancer (LAPC). The current generation of the Company's product candidate is CypCaps. The Company is preparing to commercialize cellular therapies for cancer and advance clinical research and development, including a clinical trial in LAPC using encapsulated live cells. Its candidate therapy involves encapsulating genetically engineered human cells that convert an inactive chemotherapy drug into its active, cancer-killing form.

About MEGL Magic Empire Global Limited

Magic Empire Global Ltd is a financial services provider in Hong Kong which principally engage in the provision of corporate finance advisory services and underwriting services. The company's offerings mainly comprise of IPO sponsorship services, Financial advisory and independent financial advisory services, Compliance advisory services, Underwriting services, Corporate service.

Share on Social Networks: